The Horizons Tracker

NOVEMBER 4, 2021

As failure has become a more acceptable part of innovation, one would assume that organizations have also become better at dealing with employees who make mistakes, but, of course, there are mistakes made in the pursuit of something challenging and innovative, and there are mistakes out of incompetence or malfeasance.

How To 137

How To Pharmaceuticals Innovation Learning-by-Doing 137

The Horizons Tracker

MARCH 2, 2020

There is therefore a need for complete transparency and clarity on how pharmaceutical manufacturers will use and handle this data.”. For instance, the pharmaceutical manufacturer might store the data collected, and it’s far from certain that this data will be stored in anonymized form and it may be stored indefinitely.

Ethics 80

Ethics Pharmaceuticals Uncertainty Self-aware 80

Leading Blog

AUGUST 14, 2018

I N TODAY'S competitive environment, where latecomers can copy almost any product or service, companies can no longer just be good at what they do. We can’t stand on what got us here, we must innovate. * * * Like us on Instagram and Facebook for additional leadership and personal development ideas. * * *.

How To 166

How To Core Competence Pharmaceuticals Creativity 166

Lead Change Blog

JULY 6, 2015

The only output they refer to is “superior value,” which doesn’t specify their product or service. The second example, from a pharmaceutical company, states their purpose is “to discover, develop, and deliver innovative medicines that help patients prevail over serious diseases.” Just about everyone.

Pharmaceuticals 150

Pharmaceuticals Discount Cooper Tactics 150

The Horizons Tracker

OCTOBER 21, 2021

What’s more, the more competitive the market was, the more keen developers were to ensure they got the right level of attention to ensure that their product was sufficiently differentiated to stand out. Securing help. Often this dynamic seems to prompt publishers to prefer working with these more experienced partners.

Entrepreneur 129

Entrepreneur Biotechnology Pharmaceuticals Marketing 129

Strategy Driven

DECEMBER 18, 2020

Gayhardt states that Hong Kong is already increasing its use of advanced fraud detection, biometric facial recognition, and other innovative AI technologies due to the pandemic. Fewer people building products, packaging them, transporting them, or selling them means fewer products on the shelf.

Supply Chain 85

Supply Chain Retail Pharmaceuticals Technology 85

Tanveer Naseer

MARCH 10, 2015

The following is a guest piece by Innovation Excellence co-founder Rowan Gibson. What most companies understand now is that the only way to drive profitable growth and wealth creation over the longer term is to innovate. But that’s not the way radical innovators envisage their organizations. This is quite understandable.

How To 100

How To Retail Core Competence Innovation 100

The Horizons Tracker

FEBRUARY 22, 2022

It’s a coexistent relationship that allows for considerable data to be generated that supporters believe drives productivity and allows organizations to find the optimum configuration of their facilities. It’s a market that is already worth $3.1

Stephenson 114

Stephenson Wireless Christensen Automotive 114

Strategy Driven

JUNE 22, 2018

It’s a sure sign that the products or services that you are offering are quality and that you are providing customer satisfaction. When your operational and back office processes are aligned you work efficiently and productively. Here are 5 signs that you are ready to expand: 1. You have a loyal customer base. You identify gaps.

Audience 50

Audience Niche Marketing How To Marketing Strategy 50

Harvard Business Review

AUGUST 3, 2016

That can benefit consumers through lower prices, more innovation, and better products. This is especially true in pharmaceutical markets where new and affordable drugs can improve and even save the lives of many people. Research has shown that pharma mergers reduce innovation. What’s the reason for this?

Innovation 8

Innovation Pharmaceuticals Company Price 8

Lead on Purpose

SEPTEMBER 8, 2009

Over 150 companies, including Durkee, Cremora, San Giorgio, Ronzoni, and McCormick, now use the entire line of Flapper products, and Weatherchem continues to lead the industry in offering the widest, most innovative array of closure products.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

SEPTEMBER 21, 2018

Corporate directors and executives alike recognize that today’s pace of change continues to accelerate and that firms need to innovate to stay ahead. But are boards doing enough to support innovation, as they should? We found that, overall, innovation does not rank as a top strategic challenge for the majority of boards.

Innovation 10

Innovation Short-term Telecommunications Long-term 10

Strategy Driven

DECEMBER 13, 2018

A few years back, I coached a national pharmaceutical team with distinct geographies. Strong Identity is a by-product of being able to relate to and feel good about the team, what it stands for, and the success it creates, as well as the relationships and camaraderie experienced by its members. It takes effort, energy and time.

Team 59

Team Pharmaceuticals Project Learning-by-Doing 59

Strategy Driven

JULY 13, 2011

They might include sales productivity metrics such as market share, the company’s ability to charge premium prices relative to peers, or sales force productivity. Operating-cost productivity metrics might include the component costs for building an automobile or delivering a package, the rates of rework, and so forth.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

SEPTEMBER 23, 2014

I often hear this question when I visit companies and speak about how to make an innovative idea less terrifying to high level executives. There are plenty of pundits arguing that big companies need to innovate, and pointing out that it is difficult to do so. Have you actually seen this done?”. The skepticism is warranted.

Innovation 11

Innovation P&L Short-term Company 11

Harvard Business Review

FEBRUARY 16, 2017

Most businesses wouldn’t survive without driving demand for their products or services, either through marketing and advertising or through involving users so deeply in the design of the product that word of mouth spurs adoption. The same is true for social innovators. Consider that 86 million U.S.

Innovation 9

Innovation Rogers NGO Participative 9

Harvard Business Review

JUNE 7, 2012

You don’t cut prices by 90% through marginal improvements in existing products. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. Or you could completely undercut industry pricing models by, say, 90%. Incremental change doesn’t disrupt an industry; radical change does," they note.

Disruptive Innovation 22

Disruptive Innovation Innovation Pharmaceuticals Class 22

Harvard Business Review

SEPTEMBER 15, 2011

What they found is that America's patent system only provides positive incentives for innovation in two industries: pharmaceuticals and chemicals. Anyone innovating outside of those two industries would be better off if there were no patent system at all.

Innovation 12

Innovation Chemicals Incentives Pharmaceuticals 12

Harvard Business Review

JANUARY 27, 2016

Much fanfare has been paid to the term “disruptive innovation” over the past few years. Disruptive innovations are: Cheaper (from a customer perspective). Because disruptive products were cheaper, more accessible, and built on new technology architectures, they tended to be crummier than the existing highest-end solutions.

Disruptive Innovation 8

Disruptive Innovation Innovation Short-term Long-term 8

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. If it's not, the already big and already rich will dominate innovation. Some of this may just be the product of the high regulatory costs in pharmaceuticals, but research by Harvard's F.M.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

Harvard Business Review

MARCH 28, 2012

The Swiss pharmaceutical giant Roche is nothing if not determined in its quest to acquire Illumina, the San Diego-based leader in genetic-sequencing equipment. An acquirer looking for innovation would have been likelier to try to buy Gateway, a company that is almost an after-thought now. billion tender offer directly to shareholders.

Innovation 13

Innovation Company Biotechnology CFO 13

Harvard Business Review

DECEMBER 23, 2016

When partners in an alliance come into conflict, it can be just what is needed to produce a technically and commercially successful product. Heat degrades the substrate of innovation, while light catalyzes it.” ” This idea that disagreement and conflict between groups can be productive is not new.

Productivity 8

Productivity Products Survey Strategic Fit 8

Coaching Tip

MARCH 15, 2011

All it takes is the desire to be innovative and creative in tackling a problem. Al Weatherhead is the author of The Power Of Adversity and chairman and CEO of Weatherchem, a private manufacturer of plastic closures for food, spice, pharmaceutical and nutraceutical products. Entrepreneurship.

Pharmaceuticals 84

Pharmaceuticals Creativity Long-term Power 84

Harvard Business Review

SEPTEMBER 14, 2011

We recently visited the brand-new R&D lab of Dr Reddy's , one of India's leading pharmaceutical firms. Chirotech specializes in biocatalysis and chemocatalysis, two important subspecialties of biotechnology and chemistry that help develop key biological and chemical intermediates needed for the efficient production of medicines.

Globalization 9

Globalization Innovation Decentralization Chemicals 9

Harvard Business Review

JUNE 29, 2015

And a recent working paper out of the Dusseldorf Institute for Competition Economics ( DICE ), a think tank of sorts, focuses on the latter by exploring whether leveraged buyouts (LBOs) make firms more innovative. PE investors don’t typically invest in firms known for innovation. ” There were other limitations. .

LBO 8

LBO Innovation Sample Short-term 8

Harvard Business Review

DECEMBER 20, 2011

The two biggest product stories of 2011 were arguably Lipitor and the iPhone 4S. The iPhone 4S's story seems to be about a new beginning: the highly anticipated launch of the latest version of a blockbuster consumer-technology product. 30) of a blockbuster prescription drug. Both Pfizer and. Lipitor's Long Good-bye.

Disintermediation 15

Disintermediation Industry Pharmaceuticals Price 15

Harvard Business Review

SEPTEMBER 5, 2013

With scarcely any help from management, knowledge workers can increase their productivity by 20%. Knowledge workers own the means of production — their brains. So large-scale re-engineering programs, productivity drives, and changes to the incentive system are unlikely to work: they can easily be resisted, ignored or gamed.

Productivity 8

Productivity Products Peer Review Short-term 8

Harvard Business Review

JUNE 7, 2012

You don’t cut prices by 90% through marginal improvements in existing products. Pharmaceutical patent expirations are increasing the use of cheaper generic drugs. Or you could completely undercut industry pricing models by, say, 90%. Incremental change doesn’t disrupt an industry; radical change does," they note.

Disruptive Innovation 12

Disruptive Innovation Innovation Pharmaceuticals Class 12

Harvard Business Review

MARCH 27, 2024

Learn how to repackage your company’s existing knowledge to pioneer new products and services.

Long-term 18

Long-term Competitive Advantage Productivity Products 18

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. But why not?

Business Model 15

Business Model Company Pharmaceuticals Price 15

Harvard Business Review

JUNE 9, 2017

Few issues are more foundational to driving improvements in human health than creating productive, progressive relationships between clinical medicine and the biopharmaceutical industry. How the most innovative providers are creating value. Insight Center. The Leading Edge of Health Care. Sponsored by Optum. Practicing physicians.

Conflict of Interest 10

Conflict of Interest Pharmaceuticals Policies Industry 10

Harvard Business Review

MAY 7, 2015

The model used advanced analytics to make specific recommendations about which products and services to offer to each customer based on analysis of past purchases within that account, as well as purchases in other accounts with a similar profile (i.e. In the pharmaceutical industry, technology is transforming the sales process.

Trends 8

Trends Technology Pharmaceuticals Team 8

Harvard Business Review

JUNE 13, 2016

Since 1999, three years after OxyContin was unveiled by Purdue Pharmaceuticals, the rate of drug overdoses in the U.S. Meanwhile, the amount of prescription opioids sold by pharmaceutical companies has quadrupled, despite no proliferation in the amount of reported pain. And what can we learn from it?

Incentives 8

Incentives Pharmaceuticals Crisis P&L 8

Harvard Business Review

OCTOBER 26, 2017

“He that will not apply new remedies must expect new evils; for time is the greatest innovator,” stated Francis Bacon. As with many clusters, a university sits at its center: founded in AD 1088, the Studium of Bologna was the major educational innovation of Europe’s second millennium.

Education 8

Education Pharmaceuticals Innovation Industry 8

Harvard Business Review

FEBRUARY 21, 2012

Having a strong domestic manufacturing base is vital to the United States maintaining its world leadership in innovation. Working in these plants are inventive people who are the source of important ideas for making products better or in different ways. Manufacturing provides the foundation for many kinds of innovations.

Supply Chain 15

Supply Chain Offshoring Engineering Pharmaceuticals 15

Harvard Business Review

FEBRUARY 29, 2016

We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. The occurrence of a serious error — such as a shuttle explosion, a large-scale oil spill, or a safety-related product recall — triggers the learning cycle. New executives take the helm.

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

AUGUST 9, 2012

Selling pharmaceuticals in Latin America is not the same as selling them in the United States or Western Europe. Second, in most Latin American countries, pharmaceutical companies are not allowed to advertise directly to consumers. Right off the bat, I can identify four big differences.

Pharmaceuticals 14

Pharmaceuticals Strategy Advertising Price 14